Brief: Alzchem Confirms Full-year 2026 Outlook
30/07/2026 05:57
BRIEF-Alzchem Confirms Full-year 2026 Outlook July 30 (Reuters) - ALZCHEM GROUP AG ACT1.DE:
ALZCHEM GROUP H1 EBITDA EUR 64.5 MILLION
H1 2026 GROUP SALES INCREASE 6% TO EUR 303.90 MILLION
FORECAST IS CONFIRMED: FURTHER INCREASES IN SALES AND EBITDA EXPECTED
CONFIRMS FY2026 FORECAST AND EXPECTS PROFITABLE GROWTH
Source text: ID:nEQ1x8cr3a
Further company coverage: ACT1.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on AlzChem AG
See all newsGermany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Brief: Alzchem Confirms Full-year 2026 Outlook
Brief: Alzchem Selects Bushy Park, South Carolina For Nitroguanidine Production Facility
Germany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group